Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Health of linguistic communities
Health of linguistic communities
Health Profile of Linguistic Communities in Québec
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles and prevention of chronic illnesses
Lifestyles and prevention of chronic illnesses
Healthy eating and active lifestyle
Healthy eating and active lifestyle
Health-promoting environments
TOPO
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Tobacco and electronic cigarettes
Back
Back
Laboratories and testing services
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Medical Device Reprocessing
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental health and toxicology
Environmental health and toxicology
Water, food, soil and products
Water, food, soil and products
Per- and polyfluoroalkyl substances (PFAS)
Back
Air quality, environmental noise and non-ionizing radiation
Air quality, environmental noise and non-ionizing radiation
Air quality
Back
Surveillance, skills development, and evaluation approaches in environmental health
Surveillance, skills development, and evaluation approaches in environmental health
Post-Disaster Mental Health Impacts Surveillance Toolkit
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period May 18 to 24, 2025)
Back
Exit
Back
Search
Search by keywords
Search by keywords
Hugues Charest
Publications
INSPQ
2020
Comparaison des hospitalisations dues à la COVID-19 pendant la première vague à celles dues à l’influenza pendant les saisons précédentes
2004
Surveillance passive des entérocoques résistants à la vancomycine : rapport 2002
Articles
2024
The Changing Landscape of Respiratory Viruses Contributing to Hospitalizations in Quebec, Canada: Results From an Active Hospital-Based Surveillance Study
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
2022
Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
Detection and Sequencing of Multiple Human Norovirus Genotypes from Imported Frozen Raspberries Linked to Outbreaks in the Province of Quebec, Canada, in 2017
2021
Persistence of Infectivity in Elderly Individuals Diagnosed with SARS-CoV-2 Infection 10 Days after Onset of Symptoms: A Cross-Sectional Study
SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells
A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada
Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection using a laboratory-developed test
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
Infectivity of Healthcare Workers Diagnosed with SARS-CoV-2 Infection Approximately 2 weeks after Onset of Symptoms: a Cross-Sectional Study
2020
Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017
Real-time PCR-based SARS-CoV-2 detection in Canadian Laboratories
Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
2019
HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004-2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America
A short-term assessment of nascent HIV-1 transmission clusters among newly diagnosed individuals using envelope sequence-based phylogenetic analyses
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic
Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
2018
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
2017
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada
HIV-1 envelope sequence-based diversity measures for identifying recent infections
2016
Temporal Changes in Pediatric Gastroenteritis after Rotavirus Vaccination in Quebec.
Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada.
2015
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season
Draft Genome Sequences of Two Toxigenic Corynebacterium ulcerans Strains.
Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.
2014
Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season
A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load
Genomic characterization of a large outbreak of Legionella pneumophila serogroup 1 strains in Quebec City, 2012
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses
2010
Contagious period for pandemic (H1N1) 2009
2005
Epidemiological survey of human metapneumovirus infection in a large pediatric tertiary care center
Government of Quebec
Government of Quebec
